Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2005
12/28/2005EP1608364A1 Bicyclo-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
12/28/2005EP1608363A1 Methods for treating inflammatory conditions or inhibiting jnk
12/28/2005EP1608362A1 Stabilized pharmaceutical preparation comprising an amorphous active substance
12/28/2005EP1608361A2 Compositions of cyclooxygenase-2 selective inhibitors and 5-ht1b/1d agonists for the treatment and prevention of migraine
12/28/2005EP1608360A1 Synergistic hepatoprotective composition and a method thereof
12/28/2005EP1608359A2 Tumor-targeting drug-loaded particles
12/28/2005EP1608358A1 Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof
12/28/2005EP1608357A2 Treating or preventing hot flashes using prodrugs of gaba analogs
12/28/2005EP1608356A2 Compositions for treating microbial and parasitic infections in cattle and other animals
12/28/2005EP1608355A2 Use of nep-associated molecules for treating non-immunogenic, non-hypertensive civilisation diseases
12/28/2005EP1608354A1 Compounds having serotonin 5-ht7 receptor antagonist activity and muscarinic m4 receptor agonist activity and their use in the treatment of psychotic disorders
12/28/2005EP1608353A1 Prevention and treatment of breast cancer with 4-hydroxy tamoxifen
12/28/2005EP1608352A1 Polyamine compounds for treating chemokine receptor mediated diseases
12/28/2005EP1608351A2 Compositions containing superoxide dismutase and a selected et 5-lipoxygenase inhibitor and uses thereof
12/28/2005EP1608350A1 Methods of preventing, treating and diagnosing disorders of protein aggregation
12/28/2005EP1608349A1 Oral delivery system comprising an antibacterial and an anti-inflammatory agent
12/28/2005EP1608346A1 Alpha-hydroxy acid ester drug delivery compositions and methods of use
12/28/2005EP1608344A2 Oral formulations of cladribine
12/28/2005EP1608343A2 Cladribine formulations for improved oral and transmucosal delivery
12/28/2005EP1608342A2 Stable lamotrigine pharmaceutical compositions and processes for their preparation
12/28/2005EP1608341A1 Water-soluble tablets of metformin
12/28/2005EP1608339A1 Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
12/28/2005EP1608338A1 Pharmaceutical compositions containing active agents having a lactone group and transition metal ions
12/28/2005EP1608335A1 Controlled release system containing saccharose acetate isobutyrate
12/28/2005EP1608333A1 Pharmaceutical compositions having reduced bitter taste
12/28/2005EP1608319A2 Improved inhibitors for the soluble epoxide hydrolase
12/28/2005EP1608317A2 Dipeptidyl peptidase inhibitors
12/28/2005EP1608315A2 Treating immunological disorder using agonists of interleukin-21/ interleukin-21 receptor
12/28/2005EP1608313A2 Facially amphiphilic polymers and oligomers and uses thereof
12/28/2005EP1608311A1 Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy
12/28/2005EP1608310A2 Methods and compositions for blocking the calcium cascade
12/28/2005EP1608309A2 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
12/28/2005EP1608306A2 Alkyl-substituted pcdf as a treatment for prostate cancer
12/28/2005EP1608289A2 Devices, methods, and compositions to prevent restenosis
12/28/2005EP1531831B1 Fosinopril formulation
12/28/2005EP1527076B1 Dihydro-dibenzo[b,e]oxepine based selective estrogen receptor modulators, compositions and methods
12/28/2005EP1497288B1 Novel ester hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, methods for the production thereof, and use thereof as a medicament
12/28/2005EP1490013A4 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea
12/28/2005EP1485057B1 Derivatives of azaspiro compounds for the treatment of pain
12/28/2005EP1470124B1 2-(PYRIDIN-2-YLAMINO)-PYRIDO 2,3-d]PYRIMIDIN-7-ONES
12/28/2005EP1461318B9 Tetrahydroquinoline analogues as muscarinic agonists
12/28/2005EP1435983B1 Concentrate comprising green tea, grape skin extract and grape seed extract, the production thereof and the use of the same
12/28/2005EP1434779B1 Cross-linked glycopeptide-cephalosporin antibiotics
12/28/2005EP1432415B1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases
12/28/2005EP1427403B1 Valproic acid for the treatment of breast cancer, colon cancer, head and neck cancer, small cell lung carcinoma and cancer of the blood cells in combination with irradiation
12/28/2005EP1414438B1 Antineoplastic combinations
12/28/2005EP1401502B1 Pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer
12/28/2005EP1399416A4 Peptide deformylase inhibitors
12/28/2005EP1389208B1 Substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor agonists)
12/28/2005EP1385512B1 Use of pyridoindolone derivatives for preparing anticancer medicines
12/28/2005EP1382604B1 Quinoline derivative having azolyl group and quinazoline derivative
12/28/2005EP1377593B1 2-amino-propanol derivatives
12/28/2005EP1373241B1 Method for producing optically active dihydropyrones
12/28/2005EP1368023B1 Utilization of buprenorphine in urinary incontinence therapy
12/28/2005EP1365757B1 Use of xylyloxy alkyl amines for treating tinnitus
12/28/2005EP1363588B1 Pharmaceutical and cosmetic compositions for the protection of the skin from damages induced by sun radiations
12/28/2005EP1355650B1 Combination of active ingredients containing alfuzosine and apomorphine
12/28/2005EP1326643B1 Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists
12/28/2005EP1326597B1 Use of kcnq potassium channel agonists for the manufacture of a medicament for modulating bladder function
12/28/2005EP1317489B1 A mixture of non-sulfated fucose-based oligosaccharides, a cosmetic or pharmaceutical composition comprising said mixture and its use in cosmetics or pharmacy
12/28/2005EP1303641B1 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
12/28/2005EP1299352B1 Compounds to treat alzheimer's disease
12/28/2005EP1294375B1 Treatment of seborrheic dermatitis
12/28/2005EP1265867B1 Malonic acid derivates, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them
12/28/2005EP1263746B1 Substituted 8, 8a-dihydro-3ah-indeno 1,2-d]thiazoles, a method for their production and their use as medicaments
12/28/2005EP1257276B1 Antiviral azaindole derivatives
12/28/2005EP1254131B8 Extraction of flavonoids
12/28/2005EP1251843B1 Compositions for delivery of a cortisol antagonist
12/28/2005EP1246627B1 Polyanhydrides with biologically active degradation products
12/28/2005EP1245561B1 N-substituted benzyl or phenyl aromatic sulfamides compounds and the use thereof
12/28/2005EP1235565B1 Use of 5ht 3 agonists for relaxing the fundus
12/28/2005EP1224183B1 Heterocyclic sodium/proton exchange inhibitors and method
12/28/2005EP1200077B1 L-acetyl carnitine and l-propionyl carnitine composition for the prevention and treatment of kidney dysfunctions and diseases
12/28/2005EP1191937A4 Adhesive n,o-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins
12/28/2005EP1182931B1 Stable biocidal compositions
12/28/2005EP1173433B1 Cyanopyrroles as progesterone receptor agonists
12/28/2005EP1161418B1 1-acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors
12/28/2005EP1140930B1 DIBENZO a,g]QUINOLIZINIUM DERIVATIVES AND THE SALTS THEREOF
12/28/2005EP1129089B1 Spiro-indolines as y5 receptor antagonists
12/28/2005EP1124810B9 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
12/28/2005EP1117411B1 Process for the preparation of oral pharmaceutical compositions comprising biphosphonates
12/28/2005EP1117410B1 Use of bisphosphonic acid derivatives for preparing a medicine for treating lameness
12/28/2005EP1095042B1 Antiparasitic artemisinin derivatives (endoperoxides)
12/28/2005EP1084125B1 Condensed thienopyrimidines with phosphodiesterase-v inhibiting action
12/28/2005EP1082107B8 Controlled release lipoic acid
12/28/2005EP1066033B1 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
12/28/2005EP1053238B1 Therapeutic compounds
12/28/2005EP1049686B9 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
12/28/2005EP1024802B1 Cannabinol-11-oic acid derivatives useful as antiinflammatory agents and analgesics
12/28/2005EP1015106B1 Betaine product, method for its manufacture, and its use
12/28/2005EP0994093B1 Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same
12/28/2005EP0977484B1 Non-spherical and non-platelet pyrithione salts
12/28/2005EP0925356B1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/28/2005EP0920534B1 Mutations in the diabetes susceptibility genes hepatocyte nuclear factor (hnf) hnf-1alpha, hnf-1beta and hnf-4alpha
12/28/2005EP0920448B1 Truncated glial cell line-derived neurotrophic factor
12/28/2005EP0920315B1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
12/28/2005EP0918514B1 Triaryl methane compounds for the treatment of cancer, actinic keratosis and kaposi's sarcoma
12/28/2005EP0879281B1 Methods for transforming dendritic cells and activating t cells
12/28/2005EP0876387B1 Use of roxithromycin for the preparation of a medicament for improving the biological and antiviral activity of protease inhibitors
12/28/2005EP0862426B1 Compositions comprising butyrate esters of threitol and their uses
1 ... 4420 4421 4422 4423 4424 4425 4426 4427 4428 4429 4430 4431 4432 4433 4434 4435 4436 4437 4438 4439 4440 ... 7860